BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
Statutory Instruments made by the National Assembly for Wales |
||
|
You are here: BAILII >> Databases >> Statutory Instruments made by the National Assembly for Wales >> The Health and Care Act 2022 (Commencement No. 1) (Wales) Regulations 2022 No. 1202 (W. 247) (C. 93) URL: http://www.bailii.org/wales/legis/num_reg/2022/wsi_20221202_en_1.html |
||
[New search] [Help]
This is the original version (as it was originally made)This is the original version (as originally ). This item of legislation is currently only available in its original format.
Welsh Statutory Instruments
Health Services, Wales
National Health Service, Wales
Made
at 12.48 p.m. on 18 November 2022
The Welsh Ministers make the following Regulations in exercise of the powers conferred on them by section 186(2) of the Health and Care Act 2022( 1).
1. The title of these Regulations is the Health and Care Act 2022 (Commencement No. 1) (Wales) Regulations 2022.
2. Section 161(2) of the Health and Care Act 2022 comes into force on 22 November 2022.
Eluned Morgan
Minister for Health and Social Services, one of the Welsh Ministers
At 12.48 p.m. on 18 November 2022
(This note is not part of the Regulations)
These Regulations are the first commencement regulations made by the Welsh Ministers under the Health and Care Act 2022 (“ the Act”). They bring into force section 161(2) of the Act in relation to Wales on 22 November 2022.
Section 161(2) amends section 88 of the National Health Service (Wales) Act 2006. Section 88 confers a power on the Welsh Ministers to make regulations in relation to determining remuneration for persons providing pharmaceutical services. Section 161(2) of the Act amends the powers that enable regulations to be made to establish different payment arrangements for special medicinal products to include products for vaccinating and immunising, medicines or drugs used for preventing or treating pandemic or potential pandemic diseases, and associated products.
